Mikael Sörberg

1.1k total citations
31 papers, 888 citations indexed

About

Mikael Sörberg is a scholar working on Surgery, Small Animals and Gastroenterology. According to data from OpenAlex, Mikael Sörberg has authored 31 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 8 papers in Small Animals and 8 papers in Gastroenterology. Recurrent topics in Mikael Sörberg's work include Helicobacter pylori-related gastroenterology studies (18 papers), Veterinary medicine and infectious diseases (8 papers) and Gastroesophageal reflux and treatments (7 papers). Mikael Sörberg is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (18 papers), Veterinary medicine and infectious diseases (8 papers) and Gastroesophageal reflux and treatments (7 papers). Mikael Sörberg collaborates with scholars based in Sweden, Vietnam and Finland. Mikael Sörberg's co-authors include Marta Granström, Carina Bengtsson, Thi Thu Ha Hoang, Lennart Nilsson, Håkan Hanberger, Dac Cam Phung, Lars Engstrand, Måns Nilsson, Göran Kronvall and Anna Farra and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Mikael Sörberg

31 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Sörberg Sweden 16 548 186 183 160 155 31 888
N Parasakthi Malaysia 16 394 0.7× 202 1.1× 274 1.5× 65 0.4× 117 0.8× 53 771
M. Bergeret France 17 762 1.4× 310 1.7× 128 0.7× 169 1.1× 100 0.6× 51 987
M. Labbé Belgium 8 292 0.5× 82 0.4× 65 0.4× 42 0.3× 77 0.5× 14 387
M Fuksa Canada 12 455 0.8× 92 0.5× 172 0.9× 85 0.5× 151 1.0× 19 727
Wolfgang Barousch Austria 9 154 0.3× 38 0.2× 215 1.2× 42 0.3× 37 0.2× 14 455
E.C. Nista Italy 13 528 1.0× 423 2.3× 117 0.6× 56 0.3× 133 0.9× 20 1.1k
Hanne Colding Denmark 14 119 0.2× 25 0.1× 101 0.6× 50 0.3× 39 0.3× 33 471
B. Bourke Ireland 16 376 0.7× 151 0.8× 242 1.3× 77 0.5× 60 0.4× 38 810
J C Thijs Netherlands 20 1.0k 1.9× 393 2.1× 172 0.9× 147 0.9× 325 2.1× 33 1.3k
Karin Wreiber Sweden 8 202 0.4× 62 0.3× 51 0.3× 43 0.3× 63 0.4× 9 434

Countries citing papers authored by Mikael Sörberg

Since Specialization
Citations

This map shows the geographic impact of Mikael Sörberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Sörberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Sörberg more than expected).

Fields of papers citing papers by Mikael Sörberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Sörberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Sörberg. The network helps show where Mikael Sörberg may publish in the future.

Co-authorship network of co-authors of Mikael Sörberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Sörberg. A scholar is included among the top collaborators of Mikael Sörberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Sörberg. Mikael Sörberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knudsen, Torben, et al.. (2022). Sleep quality and quantity determined by polysomnography in mechanically ventilated critically ill patients randomized to dexmedetomidine or placebo. Acta Anaesthesiologica Scandinavica. 67(1). 66–75. 18 indexed citations
4.
Rytilä, Paula, et al.. (2018). Switch from Symbicort Turbuhaler to Bufomix Easyhaler; a real-life prospective study in asthma patients. PA3998–PA3998. 3 indexed citations
5.
Nunes, Sílvia, Sune Forsberg, Hans C. Blomqvist, et al.. (2018). Effect of Sedation Regimen on Weaning from Mechanical Ventilation in the Intensive Care Unit. Clinical Drug Investigation. 38(6). 535–543. 12 indexed citations
6.
Nguyễn, Thị Việt Hà, Carina Bengtsson, Li Yin, et al.. (2012). Eradication of Helicobacter pylori in Children in Vietnam in Relation to Antibiotic Resistance. Helicobacter. 17(4). 319–325. 24 indexed citations
8.
Nguyễn, Thị Việt Hà, Carina Bengtsson, Thi Thu Ha Hoang, et al.. (2008). Evaluation of Two Triple‐Therapy Regimens with Metronidazole or Clarithromycin for the Eradication of H. pylori Infection in Vietnamese Children: a Randomized, Double‐Blind Clinical Trial. Helicobacter. 13(6). 550–556. 14 indexed citations
9.
Hoang, Thi Thu Ha, et al.. (2006). Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populations. Clinical Microbiology and Infection. 12(11). 1112–1117. 19 indexed citations
10.
Hoang, Thi Thu Ha, et al.. (2005). Long‐term follow‐up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Alimentary Pharmacology & Therapeutics. 21(8). 1047–1053. 37 indexed citations
11.
Käyhty, Helena, et al.. (2005). Immunogenicity and Tolerability of a Heptavalent Pneumococcal Conjugate Vaccine Administered at 3, 5 and 12 Months of Age. The Pediatric Infectious Disease Journal. 24(2). 108–114. 81 indexed citations
12.
Tindberg, Ylva, Thomas Casswall, Mats Blennow, et al.. (2004). Helicobacter pylori eradication in children and adolescents by a once daily 6‐day treatment with or without a proton pump inhibitor in a double‐blind randomized trial. Alimentary Pharmacology & Therapeutics. 20(3). 295–302. 11 indexed citations
13.
Granström, Marta, et al.. (2004). The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics. 19(12). 1315–1321. 22 indexed citations
14.
Hedlund, Jonas, Mikael Sörberg, Birgitta Henriques Normark, & Göran Kronvall. (2003). Capsular Types and Antibiotic Susceptibility of Invasive Streptococcus pneumoniae Among Children in Sweden. Scandinavian Journal of Infectious Diseases. 35(8). 452–458. 27 indexed citations
15.
Tindberg, Ylva, Mikael Sörberg, Thomas Casswall, et al.. (2003). Concordance ofHelicobacter pyloriStrains within Families. Journal of Clinical Microbiology. 41(12). 5604–5608. 102 indexed citations
16.
Hoang, Thi Thu Ha, et al.. (2003). Helicobacter pylori eradication and peptic ulcer healing: the impact of deleting the proton pump inhibitor and using a once‐daily treatment. Alimentary Pharmacology & Therapeutics. 18(1). 93–100. 15 indexed citations
17.
Hanberger, Håkan, Lennart E. Nilsson, Berndt E. B. Claesson, et al.. (1999). New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units. Journal of Antimicrobial Chemotherapy. 44(5). 611–619. 15 indexed citations
18.
Sörberg, Mikael, Håkan Hanberger, Maud Nilsson, Anders Björkman, & Lennart Nilsson. (1998). Risk of Development of In Vitro Resistance to Amoxicillin, Clarithromycin, and Metronidazole inHelicobacter pylori. Antimicrobial Agents and Chemotherapy. 42(5). 1222–1228. 22 indexed citations
19.
Strøm, Morten B., Mikael Sörberg, & K. Jönsson. (1997). Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori. Alimentary Pharmacology & Therapeutics. 11(2). 311–316. 13 indexed citations
20.
Sörberg, Mikael, Måns Nilsson, Håkan Hanberger, & Lennart Nilsson. (1996). Morphologic conversion ofHelicobacter pylori from bacillary to coccoid form. European Journal of Clinical Microbiology & Infectious Diseases. 15(3). 216–219. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026